| |
| |
|
| Insider
Information: |
Baker Mark Robert |
| Relationship: |
CEO, Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
161,141 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$660,678 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
161,141 |
|
|
| Total
Value |
$660,678 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
CEO, Director |
2013-03-27 |
161,141 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2008-07-01 |
4 |
D |
$16.05 |
$71,053 |
D/D |
(4,427) |
25,925 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2008-10-01 |
4 |
OE |
$6.53 |
$15,626 |
D/D |
2,393 |
28,827 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2008-10-01 |
4 |
D |
$13.93 |
$22,720 |
D/D |
(1,631) |
27,196 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2009-01-02 |
4 |
OE |
$9.13 |
$18,561 |
D/D |
2,033 |
29,336 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2009-01-02 |
4 |
D |
$10.74 |
$19,858 |
D/D |
(1,849) |
27,487 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2009-04-01 |
4 |
D |
$6.65 |
$19,238 |
D/D |
(2,893) |
24,762 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2009-04-01 |
4 |
OE |
$5.65 |
$17,967 |
D/D |
3,180 |
27,942 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2009-10-01 |
4 |
D |
$5.01 |
$18,231 |
D/D |
(3,639) |
29,915 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2009-10-01 |
4 |
OE |
$4.26 |
$17,032 |
D/D |
3,999 |
33,554 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2010-01-04 |
4 |
D |
$4.45 |
$19,113 |
D/D |
(4,295) |
30,588 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2010-01-04 |
4 |
OE |
$3.78 |
$17,856 |
D/D |
4,720 |
34,883 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2010-03-18 |
4 |
AS |
$5.33 |
$11,539 |
D/D |
(2,165) |
28,423 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2010-06-22 |
4 |
S |
$5.66 |
$13,186 |
D/D |
(2,328) |
26,689 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2010-07-01 |
4 |
OE |
$4.44 |
$20,313 |
D/D |
4,575 |
31,503 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2010-07-01 |
4 |
D |
$5.35 |
$21,978 |
D/D |
(4,108) |
27,395 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2010-10-01 |
4 |
OE |
$4.32 |
$75,759 |
D/D |
17,545 |
45,158 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2010-10-01 |
4 |
D |
$5.08 |
$81,138 |
D/D |
(15,972) |
29,186 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2011-01-03 |
4 |
OE |
$4.83 |
$21,132 |
D/D |
4,377 |
33,765 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2011-01-03 |
4 |
D |
$5.68 |
$22,800 |
D/D |
(4,014) |
29,751 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2011-04-01 |
4 |
D |
$6.29 |
$22,330 |
D/D |
(3,550) |
30,467 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2011-04-01 |
4 |
OE |
$5.05 |
$20,311 |
D/D |
4,022 |
34,017 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2011-04-27 |
4 |
AB |
$7.24 |
$3,468 |
D/D |
479 |
30,946 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2011-05-25 |
4 |
AB |
$7.13 |
$3,465 |
D/D |
486 |
31,432 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2011-06-22 |
4 |
AB |
$7.08 |
$3,469 |
D/D |
490 |
31,922 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2011-07-01 |
4 |
OE |
$5.46 |
$109,375 |
D/D |
20,032 |
52,254 |
0 |
- |
|
76 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
